Cell therapy for reducing HIV reservoir
Part of Immune system & allergy, Infections clinical trials.
This trial tests a new combination of a drug (chidamide) and specially engineered immune cells (NKG2D CAR-NK cells) to try to reduce the hidden HIV in your body. It may help you if you are on effective HIV treatment and your viral load is undetectable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have HIV and have been on antiretroviral therapy (ART) for at least 2 years
- You are between 18 and 65 years old
- Your viral load is undetectable (below 50 copies/mL) in your blood
- Your CD4 cell count is above 200
- Your blood counts, liver, and kidney function are within acceptable ranges
- You are willing to use effective birth control during the trial and for 1 year after
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether combining two drugs, ibalizumab and chidamide, can reduce the hidden HIV in your body. It aims to see if this combination is safe and might help control HIV better.
This study tests whether combining two or more investigational drugs that can activate the hidden HIV reservoir in your body might help eliminate it. The goal is to see if this approach is safe and could help lead to a cure for HIV.
This trial is testing a new therapy made from your own immune cells (called CAR NK cells) that are designed to fight a type of kidney disease that hasn't responded to standard treatments. It may be an option if you have membranous nephropathy, IgA nephropathy, or ANCA-associated vasculitis and previous treatments have failed.
This study tests whether a combination approach, including a drug called nicotinamide (a form of vitamin B3) and other strategies, can reduce the hidden HIV reservoir enough to allow a temporary pause in antiretroviral therapy without the virus rebounding. It is for people who have well-controlled HIV and strong immune systems.
This study tests a new combination of two drugs to see if they can reduce the 'hidden' HIV that stays in your body even when you're on regular HIV treatment. The goal is to work toward a cure, not just control.
This trial tests whether combining immune-boosting drugs with chidamide (a medication that may wake up hidden HIV) can help your body control HIV without daily antiretroviral therapy. It aims to achieve a 'functional cure,' meaning the virus stays suppressed even after stopping regular HIV meds.
Hear when a new HIV (Human Immunodeficiency Virus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.